Jefferson researchers, led by Dr. Ethan Halpern, are using contrast-enhanced ultrasound images to better detect prostate cancer. The microbubble-enhanced images help researchers identify prostate cancers that don’t require urgent treatment and monitor those tumors for signs of threatening changes.
In an interview with the Philadelphia Inquirer, Dr. Halpern explains, “The major drawback of the PSA is overtreatment. If we can distinguish who should have [surgery] and who shouldn’t, it changes the math.”
Read “Check Up: Monitoring Prostate Cancer,” “New Method for Detecting, Monitoring Prostate Cancer Being Tested” and “Contrast-enhanced ultrasound identified high-grade prostate cancer” to learn more.
No comments yet.